Robust Three-dimensional Tools to Design Inhibitors Against Drug Targets Which Lack Explicit Specificity
Dr. Moses Mohandas Prabu, The Commonwealth Medical College, speaking at Discovery Chemistry Congress 2013.
Discovery of Cancer Drug Targets using RNAi Screening with Pooled Lentiviral shRNA Libraries
Alex Chenchik, Cellecta Inc, speaking at Genomics Research Europe 2012
Management and Automation System for Complete qPCR Diagnostics Workflow
Matjaz Hren, Biosistemika, speaking at European Lab Automation 2012
BPM Technology as a Mechanism for Improvement of Automation Level in Life Sciences
Silke Holzmüller-Laue, University of Rostock, speaking at European Lab Automation 2012
UNICORE as a Tool for Processing the Data from GS FLX Instrument
Marcelina Borcz, ICM University of Warsaw, speaking at European Lab Automation 2012
siRNA Sequence Model: ReDesign Algorithm Based on Available Genome Wide Libraries Screens
Karol Kozak, Head, Computation Analysis, ETH Zurich, speaking at European Laboratory Automation 2012.
Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation
Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.
Fragment Based de novo Ligand Design: A Valuable Optimisation Tool in Fragment Based Lead Discovery
Peter Johnson, University of Leeds, speaking at Discovery Chemistry Congress 2012.
The Versatility of Fragment Screening Approaches and the Application of Fragment Binding Information in Durg Discovery
Stefan Geschwindner, AstraZeneca, speaking at Discovery Chemistry Congress 2012.
Current Challenges in Fragment-Based Drug Discovery
Roderick E Hubbard, University of York, speaking at Discovery Chemistry Congress 2012.
|<<|| 1 2 3 4 || >>|
|Showing Results 1 - 10 of 35|